These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1582448)

  • 1. Relaxant effects of BRL 38227 and pinacidil on the rat gastric fundus.
    Lefebvre RA; Horacek J
    Eur J Pharmacol; 1992 Apr; 214(1):1-6. PubMed ID: 1582448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxant effects of the potassium channel activators BRL 38227 and pinacidil on guinea-pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660.
    Buckle DR; Arch JR; Bowring NE; Foster KA; Taylor JF; Taylor SG; Shaw DJ
    Pulm Pharmacol; 1993 Mar; 6(1):77-86. PubMed ID: 8477155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents.
    Berry JL; Small RC; Foster RW
    Br J Pharmacol; 1992 Aug; 106(4):813-8. PubMed ID: 1393280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxation by cromakalim and pinacidil of isolated smooth muscle cells from canine coronary artery-multiple sites of action.
    Rhim BY; Hong KW
    Arch Int Pharmacodyn Ther; 1994; 328(1):67-81. PubMed ID: 7893192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
    Eltze M
    Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative relaxant effects of cromakalim and pinacidil on the tonic contraction of canine coronary artery induced by phorbol 12,13-dibutylate.
    Kuromaru O; Sakai K
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):493-7. PubMed ID: 8800572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
    Masuzawa K; Matsuda T; Asano M
    Br J Pharmacol; 1990 May; 100(1):143-9. PubMed ID: 2115387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K; Yamada H; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cromakalim, pinacidil and glibenclamide on cholinergic transmission in rat isolated atria.
    Fabiani ME; Story DF
    Pharmacol Res; 1995 Sep; 32(3):155-63. PubMed ID: 8745346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of the effects of potassium channel modulating agents on mouse intestinal smooth muscle.
    Yeung CK; McCurrie JR; Wood D
    J Pharm Pharmacol; 2002 Mar; 54(3):425-33. PubMed ID: 11902810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
    Wilson C
    J Auton Pharmacol; 1989 Feb; 9(1):71-8. PubMed ID: 2498342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.
    Edwards G; Henshaw M; Miller M; Weston AH
    Br J Pharmacol; 1991 Mar; 102(3):679-86. PubMed ID: 1364839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
    Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
    Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.
    Holzmann S; Kukovetz WR; Braida C; Pöch G
    Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilating effect of perivascularly applied potassium channel openers cromakalim and pinacidil in rat and cat pial arteries in situ.
    Wahl M; Parsons AA; Schilling L
    Cardiovasc Res; 1994 Dec; 28(12):1803-7. PubMed ID: 7867033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelium-dependent inhibition of cholinergic transmission in rat isolated trachea by potassium channel openers.
    Fabiani ME; Vlahos R; Story DF
    Pharmacol Res; 1996; 33(4-5):261-72. PubMed ID: 8938019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.